A detailed history of Snyder Capital Management L P transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Snyder Capital Management L P holds 138,146 shares of CRL stock, worth $28.5 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
138,146
Previous 147,342 6.24%
Holding current value
$28.5 Million
Previous $34.8 Million 7.46%
% of portfolio
0.83%
Previous 0.85%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$203.52 - $273.43 $1.87 Million - $2.51 Million
-9,196 Reduced 6.24%
138,146 $37.4 Million
Q4 2023

Feb 14, 2024

SELL
$164.52 - $238.84 $1.23 Million - $1.79 Million
-7,492 Reduced 4.84%
147,342 $34.8 Million
Q3 2023

Nov 14, 2023

SELL
$194.44 - $217.61 $103,830 - $116,203
-534 Reduced 0.34%
154,834 $30.3 Million
Q2 2023

Aug 14, 2023

SELL
$183.71 - $210.25 $1.28 Million - $1.47 Million
-6,980 Reduced 4.3%
155,368 $32.7 Million
Q1 2023

May 15, 2023

BUY
$191.89 - $259.92 $2.33 Million - $3.16 Million
12,147 Added 8.09%
162,348 $32.8 Million
Q4 2022

Feb 14, 2023

SELL
$197.11 - $250.07 $451,776 - $573,160
-2,292 Reduced 1.5%
150,201 $32.7 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $639,087 - $877,641
-3,503 Reduced 2.25%
152,493 $30 Million
Q2 2022

Aug 15, 2022

BUY
$204.13 - $302.4 $6.12 Million - $9.07 Million
29,987 Added 23.8%
155,996 $33.4 Million
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $983,202 - $1.39 Million
3,848 Added 3.15%
126,009 $35.8 Million
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $5.23 Million - $6.67 Million
-14,873 Reduced 10.85%
122,161 $46 Million
Q3 2021

Nov 15, 2021

BUY
$372.64 - $458.3 $6.94 Million - $8.54 Million
18,631 Added 15.74%
137,034 $56.6 Million
Q2 2021

Aug 16, 2021

SELL
$294.17 - $371.65 $3.92 Million - $4.95 Million
-13,329 Reduced 10.12%
118,403 $43.8 Million
Q1 2021

May 17, 2021

SELL
$249.67 - $299.48 $284,374 - $341,107
-1,139 Reduced 0.86%
131,732 $38.2 Million
Q4 2020

Feb 16, 2021

SELL
$222.0 - $252.62 $209,346 - $238,220
-943 Reduced 0.7%
132,871 $33.2 Million
Q3 2020

Nov 13, 2020

SELL
$175.56 - $226.45 $392,903 - $506,795
-2,238 Reduced 1.64%
133,814 $30.3 Million
Q2 2020

Aug 14, 2020

SELL
$118.84 - $189.72 $50,982 - $81,389
-429 Reduced 0.31%
136,052 $23.7 Million
Q1 2020

May 15, 2020

BUY
$98.9 - $178.34 $2.1 Million - $3.79 Million
21,242 Added 18.43%
136,481 $17.2 Million
Q4 2019

Feb 14, 2020

BUY
$126.05 - $152.76 $3.92 Million - $4.75 Million
31,107 Added 36.97%
115,239 $17.6 Million
Q3 2019

Nov 14, 2019

BUY
$125.07 - $143.67 $1.46 Million - $1.68 Million
11,687 Added 16.13%
84,132 $11.1 Million
Q2 2019

Aug 14, 2019

SELL
$123.4 - $148.55 $184,359 - $221,933
-1,494 Reduced 2.02%
72,445 $10.3 Million
Q1 2019

May 15, 2019

BUY
$104.82 - $146.73 $297,164 - $415,979
2,835 Added 3.99%
73,939 $10.7 Million
Q4 2018

Feb 14, 2019

SELL
$105.09 - $137.23 $615,091 - $803,207
-5,853 Reduced 7.61%
71,104 $8.05 Million
Q3 2018

Nov 14, 2018

BUY
$112.11 - $134.54 $698,781 - $838,587
6,233 Added 8.81%
76,957 $10.4 Million
Q2 2018

Aug 14, 2018

BUY
$102.37 - $117.25 $487,793 - $558,696
4,765 Added 7.22%
70,724 $7.94 Million
Q1 2018

May 14, 2018

SELL
$98.19 - $115.2 $129,610 - $152,064
-1,320 Reduced 1.96%
65,959 $7.04 Million
Q4 2017

Feb 13, 2018

BUY
$100.43 - $118.09 $1.39 Million - $1.64 Million
13,866 Added 25.96%
67,279 $7.36 Million
Q3 2017

Nov 14, 2017

BUY
$96.72 - $109.26 $5.17 Million - $5.84 Million
53,413
53,413 $5.77 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.5B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Snyder Capital Management L P Portfolio

Follow Snyder Capital Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snyder Capital Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Snyder Capital Management L P with notifications on news.